Sector revisions WuXi AppTec Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 07/07/2025			5-day change	1st Jan Change
69.84 ^CNY	-1.38%		+0.42%	+26.89%

30/06	CANbridge Pharmaceuticals Inc. Announces Board and Committee Changes, Effective June 30, 2025	CI
27/06	WuXi AppTec Buys Back 20 Million Yuan of Shares	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	WUXI APPTEC CO., LTD.							18
	REGENERON PHARMACEUTICALS, INC.							24
	ARGENX SE							16
	BIONTECH SE							21
	INSMED INCORPORATED							18
	SUMMIT THERAPEUTICS INC.							9
	WUXI BIOLOGICS (CAYMAN) INC.							26
	AKESO, INC.							20
	GENMAB A/S							16
	EXELIXIS, INC.							19
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							16
	VERONA PHARMA PLC							11
	MADRIGAL PHARMACEUTICALS, INC.							14
	LEGEND BIOTECH CORPORATION							20
	PHARMAESSENTIA CORPORATION							4
	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.							2
	BIOCON LIMITED							20
	NUVALENT, INC.							10
	SINOCELLTECH GROUP LIMITED							2
	Average							15
	Weighted average by Cap.							18